PPAR and MMP9 patients with hypertensive disorders in pregnancy placenta and its clinical significance.docVIP
- 3
- 0
- 约1.7万字
- 约 15页
- 2017-05-05 发布于浙江
- 举报
PPAR and MMP9 patients with hypertensive disorders in pregnancy placenta and its clinical significance
PAGE \* MERGEFORMAT 15
PPAR and MMP9 patients with hypertensive disorders in pregnancy placenta and its clinical significance
[Abstract] Objective To investigate the PPAR and MMP 9 in pregnancy induced hypertension (HDCP) in the development of its clinical significance. Methods Immunohistochemical SP method detected 31 cases of normal pregnancy (control group) and 36 patients with HDCP (experimental group) placenta PPAR, MMP 9 expression and its relationship with HDCP. Results PPAR in the experimental group, placental tissue was significantly higher expression compared with control group were significantly different (P lt;0.05), PPAR positive expression rate exacerbations was significantly increased. MMP 9 in the experimental group placental tissue was low expression in the control group were significantly different (P lt;0.05), MMP 9 positive expression rate of exacerbations was significantly decreased. PPAR and MMP 9 in the Pearman related analysis showed a negative correlation between the two expression levels (r =- 0.529, P lt;0.01). Conclusion PPAR in the placenta of HDCP was highly expressed, MMP 9 in the HDCP patients showed low expression in placenta, suggesting that it may inhibit trophoblast infiltration capacity in the pathogenesis of HDCP.
[Keywords:] peroxisome proliferator-activated receptor ; matrix metalloproteinase-9; pregnancy induced hypertension; placenta; Immunohistochemistry
ABSTRACT: Objective To investigate the expressions and clinical significance of PPAR and MMP 9 in the genesis and development of hypertensive disorder complicating pregnancy (HDCP). Methods The expressions of PPAR and MMP 9 in placenta of 31 normal pregnant women (control group) and 36 pregnant women with hypertensive disorder complicating pregnancy (experimental group) were detected by using SP method of immunohistochemistry, and the relationship between PPAR and MMP 9 expressions and hypertensive disorder complicating pregnancy was explored. Results PPA
您可能关注的文档
- Polygonum amphibian orthogonal extraction of alkaloids.doc
- Polygonum capitatum different collection of fingerprint similarity evaluation_0.doc
- Polygonum benzophenone synthase gene cloning and sequence analysis.doc
- Polygonum Combination Poria rat kidney and femur of.doc
- Polygonum cuspidatum resveratrol and resveratrol glucoside in the Extraction and Determination.doc
- Polygonum cuspidatum Resveratrol Extraction and Detection Method Progress.doc
- Polygonum drink hypothalamus of female aging rats of neurotransmitter.doc
- Polygonum capitatum different collection of fingerprint similarity evaluation.doc
- Polygonatum on learning and memory in aging rats and mechanism of the improvement.doc
- Polygonum multiflorum content of total flavonoids and trace elements analysis and its efficacy Mechanism.doc
- 中国国家标准 GB/T 6675.9-2025玩具安全 第9部分:化学及类似活动的实验玩具.pdf
- 《GB/T 6675.9-2025玩具安全 第9部分:化学及类似活动的实验玩具》.pdf
- GB/T 46975-2025婴童用品 便携式婴儿睡篮技术要求.pdf
- 中国国家标准 GB/T 46975-2025婴童用品 便携式婴儿睡篮技术要求.pdf
- 《GB/T 46975-2025婴童用品 便携式婴儿睡篮技术要求》.pdf
- 《GB/T 6675.14-2025玩具安全 第14部分:指画颜料要求和测试方法》.pdf
- GB/T 6675.14-2025玩具安全 第14部分:指画颜料要求和测试方法.pdf
- 中国国家标准 GB/T 6675.14-2025玩具安全 第14部分:指画颜料要求和测试方法.pdf
- 中国国家标准 GB/T 33772.3-2025质量评定体系 第3部分:印制板及层压板最终产品检验及过程监督用抽样方案的选择和使用.pdf
- 《GB/T 33772.3-2025质量评定体系 第3部分:印制板及层压板最终产品检验及过程监督用抽样方案的选择和使用》.pdf
原创力文档

文档评论(0)